Effect of transferrin-gallium on leukemic cells

Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.

Bone marrow transplantation·2004

Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF.

Bone marrow transplantation·2003

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.

Leukemia·2002

Spontaneous regression of congenital leukaemia with an 8;16 translocation.

British journal of haematology·2000

Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma.

Transplantation·2000

[Hemophagocytic syndrome].

Harefuah·2000

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Blood·2026

The hepatic FGFR-ERK-HRG axis regulates heparin-induced thrombocytopenia with thrombosis.

Blood·2026

HOW I TREAT BLEEDING IN WOMEN AND GIRLS WITH HEMOPHILIA/ HEMOPHILIA CARRIERS.

Blood·2026

FERMT3 alternative splicing enhances kindlin-3 membrane recruitment for neutrophil adhesion during stress myelopoiesis.

Blood·2026

Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study.

Blood·2026

How I treat autoimmune neutropenia in adults.

Blood·2026

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Cancer research·2026

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Cureus·2026

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Cureus·2026

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Frontiers in immunology·2026

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Frontiers in immunology·2026

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Cancer cell·2026

Related Experiment Videos

Effect of transferrin-gallium on leukemic cells

Related Concept Videos

Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.

Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF.

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.

Spontaneous regression of congenital leukaemia with an 8;16 translocation.

Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma.

[Hemophagocytic syndrome].

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

The hepatic FGFR-ERK-HRG axis regulates heparin-induced thrombocytopenia with thrombosis.

HOW I TREAT BLEEDING IN WOMEN AND GIRLS WITH HEMOPHILIA/ HEMOPHILIA CARRIERS.

FERMT3 alternative splicing enhances kindlin-3 membrane recruitment for neutrophil adhesion during stress myelopoiesis.

Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study.

How I treat autoimmune neutropenia in adults.

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Related Experiment Videos

Effect of transferrin-gallium on leukemic cells

Related Concept Videos

Related Articles